- Type / Class
- Equity / COM
- Shares outstanding
- 258,506,508
- Total 13F shares
- 24,011,278
- Share change
- +102,949
- Total reported value
- $1,580,908,389
- Put/Call ratio
- 106%
- Price per share
- $65.84
- Number of holders
- 163
- Value change
- +$28,478,384
- Number of buys
- 83
- Number of sells
- 78
Quarterly Holders Quick Answers
What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29664W105:
Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Meditor Group Ltd |
13F
|
Company |
0.89%
|
2,294,935
|
$115,022,000 | — | 30 Sep 2017 | |
| Pentwater Capital Management LP |
13F
|
Company |
0.87%
|
2,243,200
|
$112,429,000 | — | 30 Sep 2017 | |
| BB BIOTECH AG |
13F
|
Company |
0.81%
|
2,097,964
|
$105,150,000 | — | 30 Sep 2017 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.59%
|
1,521,674
|
$76,267,000 | — | 30 Sep 2017 | |
| FMR LLC |
13F
|
Company |
0.52%
|
1,342,888
|
$67,306,000 | — | 30 Sep 2017 | |
| STATE STREET CORP |
13F
|
Company |
0.49%
|
1,260,414
|
$63,166,000 | — | 30 Sep 2017 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.41%
|
1,064,038
|
$53,330,000 | — | 30 Sep 2017 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.34%
|
880,323
|
$44,121,000 | — | 30 Sep 2017 | |
| Aisling Capital LLC |
13F
|
Company |
0.32%
|
837,125
|
$41,957,000 | — | 30 Sep 2017 | |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT |
13F
|
Company |
0.3%
|
783,059
|
$39,247,000 | — | 30 Sep 2017 | |
| PINNACLE ASSOCIATES LTD |
13F
|
Company |
0.28%
|
717,813
|
$35,977,000 | — | 30 Sep 2017 | |
| WASATCH ADVISORS LP |
13F
|
Company |
0.28%
|
713,404
|
$35,756,000 | — | 30 Sep 2017 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.22%
|
577,917
|
$28,965,000 | — | 30 Sep 2017 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.21%
|
548,682
|
$27,500,000 | — | 30 Sep 2017 | |
| Boxer Capital, LLC |
13F
|
Company |
0.19%
|
500,000
|
$25,060,000 | — | 30 Sep 2017 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.15%
|
393,150
|
$19,705,000 | — | 30 Sep 2017 | |
| Rhenman & Partners Asset Management AB |
13F
|
Company |
0.12%
|
311,803
|
$15,628,000 | — | 30 Sep 2017 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.12%
|
306,455
|
$15,360,000 | — | 30 Sep 2017 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.11%
|
290,027
|
$14,536,000 | — | 30 Sep 2017 | |
| Aviva Holdings Ltd. |
13F
|
Company |
0.11%
|
289,100
|
$14,490,000 | — | 30 Sep 2017 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.1%
|
259,096
|
$12,986,000 | — | 30 Sep 2017 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.1%
|
250,000
|
$12,583,000 | — | 30 Sep 2017 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.09%
|
235,889
|
$11,823,000 | — | 30 Sep 2017 | |
| GAM Holding AG |
13F
|
Company |
0.09%
|
225,000
|
$11,277,000 | — | 30 Sep 2017 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.08%
|
201,476
|
$10,097,977 | — | 30 Sep 2017 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.07%
|
189,899
|
$9,517,000 | — | 30 Sep 2017 | |
| MUFG Securities EMEA plc |
13F
|
Company |
0.07%
|
180,000
|
$9,022,000 | — | 30 Sep 2017 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
176,611
|
$8,851,000 | — | 30 Sep 2017 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
174,097
|
$8,726,000 | — | 30 Sep 2017 | |
| CREDIT AGRICOLE S A |
13F
|
Individual |
0.06%
|
157,900
|
$7,914,000 | — | 30 Sep 2017 | |
| Iguana Healthcare Management, LLC |
13F
|
Company |
0.06%
|
150,000
|
$7,518,000 | — | 30 Sep 2017 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.06%
|
142,981
|
$7,166,000 | — | 30 Sep 2017 | |
| Quantitative Investment Management, LLC |
13F
|
Company |
0.05%
|
123,600
|
$6,194,000 | — | 30 Sep 2017 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
117,987
|
$5,912,000 | — | 30 Sep 2017 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
115,372
|
$5,783,000 | — | 30 Sep 2017 | |
| UBS Group AG |
13F
|
Company |
0.04%
|
104,191
|
$5,223,000 | — | 30 Sep 2017 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.04%
|
103,726
|
$5,199,000 | — | 30 Sep 2017 | |
| Informed Momentum Co LLC |
13F
|
Company |
0.04%
|
92,899
|
$4,656,000 | — | 30 Sep 2017 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.04%
|
91,843
|
$4,604,000 | — | 30 Sep 2017 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
91,480
|
$4,585,000 | — | 30 Sep 2017 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
90,750
|
$4,548,000 | — | 30 Sep 2017 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
83,357
|
$4,178,000 | — | 30 Sep 2017 | |
| S.c.a. Candriam |
13F
|
Individual |
0.03%
|
80,000
|
$4,010,000 | — | 30 Sep 2017 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
78,364
|
$3,928,000 | — | 30 Sep 2017 | |
| BAILARD, INC. |
13F
|
Company |
0.02%
|
63,300
|
$3,173,000 | — | 30 Sep 2017 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
61,800
|
$3,087,000 | — | 30 Sep 2017 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
58,332
|
$2,924,000 | — | 30 Sep 2017 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.02%
|
55,095
|
$2,761,000 | — | 30 Sep 2017 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.02%
|
51,997
|
$2,606,000 | — | 30 Sep 2017 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.02%
|
49,335
|
$2,473,000 | — | 30 Sep 2017 |
Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q4 2017
As of 31 Dec 2017,
Esperion Therapeutics, Inc. - COM (ESPR) was held by
163 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,011,278 shares.
The largest 10 holders included
BB BIOTECH AG, Meditor Group Ltd, Pentwater Capital Management LP, BlackRock Inc., FMR LLC, STATE STREET CORP, CREDIT SUISSE AG/, Vanguard Group Inc, Partner Fund Management, L.P., and Boxer Capital, LLC.
This page lists
163
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2017 vs Q3 2017 Across Filers
Q3 2017 holders
150
Q4 2017 holders
163
Holder diff
13
| Investor | Q3 2017 Shares | Q4 2017 Shares | Share Diff | Share Chg % | Q3 2017 Value $ | Q4 2017 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.